GLP-1 drugs: From weight loss wonder to potential heart-care tool | Bengaluru News
Bengaluru: For years, obesity and other weight-related conditions have complicated the management of cardiovascular disease. Now, as clinical trials show that glucagon-like peptide-1 (GLP-1) drugs can deliver significant weight loss even in people without diabetes, cardiac specialists in the city say the medicines could bring a shift in cardiovascular care.Dr Arunkumar Ullegaddi, consultant, adult cardiology,…
